Medical Weight Loss Treatment for Iowa Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the Iowa Board of Medicine to deliver telehealth services across all 99 counties.
Whether you're in Des Moines, Des Moines, or anywhere across Iowa — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Iowa
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Iowa's hardworking families deserve healthcare that understands their lifestyle. From the tech startups of Des Moines to the farming operations that span the state, OmniRx Health delivers. We know that harvest season doesn't stop for doctor's appointments, and that the nearest specialist might be an hour away. Our telehealth platform brings expert medical care to your farmhouse, your office in the Quad Cities, or anywhere in the Hawkeye State with internet access.
Available Treatments in Iowa
Our board-certified providers in Iowa can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Iowa
State Licensing
OmniRx Health providers are licensed by the Iowa Board of Medicine to deliver telehealth services across all 99 counties.
Telehealth Law
Iowa's telehealth laws support virtual care delivery with practical regulations that serve both urban and rural populations effectively.
Pharmacy Access
Iowa pharmacies in Des Moines, Cedar Rapids, Davenport, and rural communities provide prescription services with reliable home delivery.
Insurance Notes
Iowa insurers cover telehealth services, with Wellmark and other major carriers providing virtual visit benefits for members.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Iowa
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.